Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estradiol as adjunctive treatment for schizophrenia in women
NCT00357006Phase 2Completed
- Sponsor
- Alfred Health
- Start
- Jul 2006
- Primary completion
- Oct 2011
- Modality
- Hormone, Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of estradiol in schizophrenia, schizoaffective disorder, schizophreniform disorder, sponsored by Alfred Health. Started Jul 2006; status: completed.
02
Drugs
estradiol
03
Conditions
schizophreniaschizoaffective disorderschizophreniform disorder
Beyond the preview
Go deeper on NCT00357006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00357006.